DNA2.0 (now ATUM) Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
ATUM, formerly DNA2.0, is a biotechnology company focused on synthetic genomics. It provides an integrated workflow for gene design, optimization and synthesis, and supports platforms for protein and strain engineering. Founded in 2003, the company is based in Newark, California, and serves a global customer base spanning academia, government, and industries such as pharmaceuticals, chemicals, agriculture and biotech. In May 2026, ATUM announced the launch of its Lock-In Bispecifics Platform at the PEGS Boston Summit. The firm operates as a privately held entity within the biotechnology research sector.